Living After Prostate Cancer Treatment: Urinary Control, Intimacy and Follow-Up Visits

The last radiotherapy session ends with a handshake and a car park that looks exactly as it did six weeks earlier. Or the catheter comes out ten days after surgery and a nurse hands over a small bag of absorbent pads. Either way, the moment many men describe is the same: the treatment calendar is suddenly empty, and the question shifts from “what will they do to me?” to “who am I now?”

Life after prostate cancer treatment is rarely a straight line back to before. Bladder control returns in fits and starts. Erections may take months to reappear, if they do. Hormone therapy can flatten energy and mood in ways that surprise even people who read every leaflet. And there is the quiet anxiety of the next blood test, a small number that seems to carry enormous weight.

This guide explains what typically happens in the months and years after prostatectomy, radiotherapy or hormone treatment, what the evidence says about recovery, and where the myths end.

What life after prostate cancer treatment actually involves

Every prostate cancer treatment works by removing, destroying or starving the gland’s cancer cells, and each approach leaves its own footprint on nearby structures. The prostate sits directly beneath the bladder, wraps around the urethra (the tube that carries urine and semen out of the body), and is hugged by the nerve bundles that trigger erections. Anything that treats the prostate touches those neighbours.

Radical prostatectomy is surgery that removes the whole gland and the seminal vesicles, then stitches the bladder directly to the urethra. The internal valve that once helped hold urine is gone, so the external sphincter muscle and pelvic floor take over the job alone. Nerves may be spared or, if the tumour sits close to them, deliberately removed. According to Cleveland Clinic, this is why leaking and erection changes are the two side effects surgeons discuss most.

Radiotherapy, whether delivered from outside the body or via implanted seeds (brachytherapy), damages cancer DNA over weeks. The bladder lining and rectal wall absorb some dose, which is why urinary urgency and bowel changes can appear during treatment and, in some men, months later. The NHS notes that radiotherapy side effects can arrive gradually and sometimes persist.

Hormone therapy, also called androgen deprivation therapy, lowers testosterone because prostate cancer cells use it as fuel. Low testosterone affects far more than the prostate: muscle, bone, mood, metabolism and sexual desire all respond.

Life after prostate cancer treatment therefore means living with the specific footprint of the treatment you had. Knowing which structures were affected makes the recovery pattern far easier to understand, and far less frightening when it does not move in a straight line.

Who this guide is for, and who is usually asked to wait

This explainer is aimed at men who have completed definitive treatment, meaning surgery, a full course of radiotherapy, or the combination of radiotherapy and a fixed period of hormone therapy. It also applies to partners, who often carry a share of the physical and emotional recovery.

Not everyone with a prostate cancer diagnosis is in this position. Many men with low-risk disease are offered active surveillance, a structured program of PSA tests, examinations and repeat MRI or biopsy rather than immediate treatment. Mayo Clinic describes this as a deliberate choice to avoid side effects while the cancer is monitored closely. These men are, in a sense, asked to wait, and their “life after” question is really a “life alongside” question. The bladder and sexual changes described here do not apply to them unless they later move to treatment.

A second group is asked to wait in a different way: men who have had treatment but whose recovery work is not yet due. Surgeons commonly advise against heavy lifting or vigorous exercise for several weeks after prostatectomy while the internal join heals, so formal pelvic floor or fitness programs are often delayed until the team gives clearance. Men receiving radiotherapy are typically told to expect side effects to peak toward the end of the course and for a few weeks afterward, according to the NHS, so judging the “new normal” too early can be misleading.

Finally, men on long-term hormone therapy for advanced disease follow a different rhythm again, with ongoing treatment rather than a finish line. Much of the advice on fatigue, bone health and mood applies to them, but the follow-up schedule and goals are set individually by their oncology team.

Prostate cancer recovery timeline: the first days and weeks

The first week after prostatectomy is dominated by the catheter, a soft tube left in the bladder to let the new join between bladder and urethra heal. Cleveland Clinic notes that it usually stays in place for about one to two weeks. Once it comes out, most men leak. That is expected, not a sign of failure. Pads, loose clothing and a plan for where the nearest toilet is become practical priorities.

Pain in the lower abdomen and around small incision sites tends to ease over the first couple of weeks. Walking is encouraged early because it reduces the risk of blood clots and helps bowel function return. Heavy lifting, cycling and strenuous exercise are typically restricted for several weeks; the exact timing is decided by the surgical team.

For external beam radiotherapy, the timeline runs differently. There is no single recovery day. Urinary frequency, urgency, burning and loose stools often build during the course and, according to the NHS, may continue for a few weeks after the final session before gradually easing. Tiredness is common throughout and can linger.

Brachytherapy carries its own early pattern: urinary symptoms may be more intense in the first weeks as the prostate swells around the seeds, then settle over the following months.

Hormone therapy has no acute recovery phase, but its effects accumulate. Hot flashes and reduced libido can appear within weeks; fatigue, weight change and loss of muscle tend to show over months.

The honest summary of the prostate cancer recovery timeline is that the first month is about healing and coping, not judging outcomes. Bladder control, erections and energy are assessed over a much longer horizon, which the following sections describe.

Incontinence after prostatectomy: why it happens and how it usually changes

Urine leakage after surgery has a mechanical explanation. Before prostatectomy, continence relies on two systems: an internal sphincter at the bladder neck and an external sphincter muscle below the prostate, supported by the pelvic floor. Surgery removes the internal component. The external sphincter, which may also have been bruised or stretched during the operation, must now hold the line by itself.

Stress incontinence is the typical pattern: a few drops or a small gush when coughing, sneezing, standing up or lifting. Leakage while lying still is much less common. Some men also notice urgency, a sudden need to go, as the bladder adjusts to its new position.

The trajectory matters more than any single week. The NHS states that most men regain bladder control within a few months, though a proportion continue to leak for longer, sometimes up to a year or more. Cleveland Clinic similarly describes gradual improvement over months rather than days. Nerve-sparing technique, age, pre-existing bladder problems and prior radiotherapy all influence how quickly and how fully control returns.

A small group of men do not recover full control. For them, options range from continued conservative measures to specialist procedures, which a urologist would discuss once enough healing time has passed, commonly a year or so, so that the true baseline is clear.

Radiotherapy causes a different kind of urinary trouble. Rather than stress leakage, men more often report frequency, urgency and, occasionally, blood in the urine from irritated bladder lining. These usually improve after treatment ends, but the NHS cautions that some urinary changes can appear or persist months later.

Incontinence after prostatectomy is common, usually temporary and rarely spoken about openly. Naming it plainly at follow-up visits is the first step toward managing it.

Do pelvic floor exercises really help, and when should they start?

Pelvic floor muscle training is the one intervention for post-surgical leakage that carries consistent guideline support. The pelvic floor is the sling of muscle running from the pubic bone to the tailbone; tightening it lifts the base of the bladder and squeezes the urethra shut. After prostatectomy, this sling and the external sphincter are the entire continence mechanism.

The NHS and Cleveland Clinic both recommend these exercises for men recovering from prostate surgery, and many teams introduce them before the operation so the muscles are already trained when the catheter comes out. The technique is the same one used for women: contract as if stopping the flow of urine or holding in gas, hold, then fully relax. Full relaxation matters as much as the squeeze; a muscle held tight all day fatigues and performs worse.

A few practical points that clinicians repeat:

• Start only when the surgical team says it is safe, usually once the catheter is removed.
• Quality beats quantity; a handful of correct, isolated contractions is more useful than dozens of strained attempts that recruit the buttocks and abdomen instead.
• Practice in positions that trigger leaks, such as standing up from a chair, so the reflex “squeeze before you cough” becomes automatic.
• A pelvic health physiotherapist can confirm technique; many men are unsure whether they are contracting the right muscles at all.

Bladder habits also play a part. Caffeine, alcohol and very large fluid volumes in the evening can worsen urgency. Timed voiding, meaning emptying the bladder on a schedule rather than waiting for urgency, gives the new system predictable, manageable volumes.

What the evidence does not show is a guaranteed timeline. Training improves the odds and may shorten the course, but recovery still varies widely, and the treating team remains the judge of when further options are worth discussing.

Sex after prostate cancer treatment: erections, orgasm and what changes

Erectile dysfunction, the inability to get or keep an erection firm enough for sex, is the most discussed sexual consequence of prostate cancer treatment, but it is not the only one. Understanding the mechanism helps set realistic expectations.

Erections depend on nerves that run along the surface of the prostate. Surgery may spare one, both or neither bundle depending on where the tumour lies. Even when nerves are preserved, they are handled and stretched, and nerves recover slowly. Cleveland Clinic notes that erectile function can continue to improve for up to two years after surgery, with the first months often the poorest. Radiotherapy damages the same nerves and small blood vessels more gradually, so erection problems after radiation tend to appear later and progress over one to two years rather than arriving at once.

Hormone therapy works differently again: it removes desire as well as function, because testosterone drives libido. When the therapy is time-limited, desire often returns as testosterone recovers, though the pace varies with age and treatment duration.

Beyond erections, men commonly notice:

• Dry orgasm after prostatectomy, since the glands that make semen are removed; orgasm sensation remains possible but there is no ejaculate.
• Reduced ejaculate volume after radiotherapy.
• A small leak of urine at climax after surgery, called climacturia, which usually improves alongside continence.
• A modest reduction in penile length after surgery, described in urology literature and discussed on Cleveland Clinic patient pages.

Medicines in the phosphodiesterase type 5 inhibitor class, which improve blood flow into the penis, are often discussed as part of rehabilitation, along with vacuum devices and other approaches. Whether, when and how any of these are used is a decision for the treating urologist, who can weigh heart health, other medicines and the pattern of nerve sparing. Sex after prostate cancer treatment is usually different; it is rarely over unless a man decides it is.

Intimacy beyond erections: what partners and couples actually report

Ask partners what changed most after prostate cancer treatment and erections are seldom the first answer. Silence is. Many couples describe months of avoiding the subject entirely, each assuming the other has lost interest, when in fact both are grieving the same loss and afraid of causing disappointment.

Sexual health after cancer is increasingly framed by oncology teams as a rehabilitation goal rather than a private problem, and the NHS’s living-with-prostate-cancer guidance encourages men to raise sexual side effects with their doctor or nurse rather than assume nothing can be done. The same applies to couples’ conversations.

A few patterns come up repeatedly in clinical experience and patient support literature:

• Redefining sex as touch, closeness and mutual pleasure, rather than a single act requiring a firm erection, reduces pressure and often rekindles desire on both sides.
• Scheduling intimacy sounds unromantic but works around fatigue, pad changes and the timing of any prescribed aids.
• Partners frequently worry about causing pain or harm; a clear explanation from the team of what is physically safe, and when, removes that barrier.
• Single men face a distinct challenge in when and how to disclose changes to a new partner, and psychosexual counselling can help rehearse that conversation.

Depression and anxiety also suppress desire independently of any nerve injury, which is one reason mental health is covered later in this guide. Treating low mood sometimes does more for intimacy than any device.

Where available, psychosexual therapists or specialist nurses attached to urology or oncology services can see couples together. Referral routes vary, and the treating team is the right place to ask. What the evidence and long experience agree on is simple: couples who talk early adapt better than couples who wait for function to return before speaking.

Hormone therapy side effects: fatigue, hot flashes, bones and mood

Androgen deprivation therapy, the medical name for lowering testosterone to control prostate cancer, is often given for months alongside radiotherapy for higher-risk disease, or long term for cancer that has spread. Its side effects are systemic because testosterone acts throughout the body, and the NHS and Mayo Clinic both list a similar cluster.

Hot flashes are the most immediately noticeable: sudden waves of heat and sweating, sometimes several times a day and often at night, disrupting sleep. Fatigue follows, partly from poor sleep and partly from the direct metabolic effect of low testosterone. Muscle mass declines and fat, especially around the abdomen, tends to increase, which in turn nudges blood sugar and cholesterol in unfavourable directions.

Bone density falls with prolonged therapy, raising fracture risk over years. Mayo Clinic notes that clinicians may monitor bone density and consider bone-protecting strategies for men on long courses; what that involves is decided individually. Weight-bearing exercise, adequate calcium and vitamin D from diet or as advised by the team, and not smoking are the lifestyle pillars that support bone.

Mood changes are underestimated. Irritability, tearfulness, low motivation and reduced concentration are all reported, and they blur into the depression and anxiety that a cancer diagnosis itself can trigger. Breast tenderness or mild enlargement (gynecomastia) can occur. Libido almost always drops.

Two facts help men cope. First, when hormone therapy is time-limited, many effects reverse as testosterone recovers, although recovery is slower in older men and after longer treatment, and is not guaranteed. Second, regular aerobic and resistance exercise has good evidence for reducing fatigue and preserving muscle during therapy, which is why oncology teams increasingly prescribe movement as part of treatment rather than an optional extra.

Any concern about a hormone medicine, including whether to pause or change it, belongs with the prescribing oncologist.

PSA levels after prostate surgery and radiation: reading the follow-up numbers

Prostate-specific antigen, or PSA, is a protein made by prostate tissue, healthy or cancerous, and its blood level is the main tool for follow-up after treatment. What counts as reassuring depends entirely on which treatment you had, and this is where much anxiety comes from.

After radical prostatectomy, the entire gland is gone, so PSA should fall to an undetectable or near-zero level within a few weeks. The NHS and National Cancer Institute both describe a rising PSA after surgery as the main signal that cancer cells may remain, a situation called biochemical recurrence. Even then, a single reading is rarely acted upon; teams look at the trend over repeated tests and at how quickly the number doubles.

After radiotherapy, the picture is deliberately different. Healthy prostate tissue remains and continues to make some PSA, so the level falls slowly, often over one to two years, and reaches a low point called the nadir rather than zero. A temporary rise a year or two after brachytherapy or external beam treatment, known as a PSA bounce, is well recognised and does not necessarily mean recurrence. Oncologists typically define recurrence after radiotherapy as a sustained rise well above the nadir, not a single uptick.

During hormone therapy PSA is suppressed regardless of what the cancer is doing, and it may rise as testosterone recovers after a finite course. That expected rise is different from disease activity, which is why interpretation sits with the oncology team.

PSA levels after prostate surgery or radiation are best thought of as a moving picture, not a pass or fail grade. Ask the team what range they expect for your situation, what would prompt further tests, and how many readings they would want before drawing conclusions. Knowing the rules in advance takes much of the dread out of each result.

Follow-up visits: what to expect and how often they usually happen

Follow-up after prostate cancer treatment has three jobs: watching for recurrence, managing side effects, and supporting general health. The rhythm is set by the treating team and shaped by cancer risk, treatment type and how recovery is going, but broad patterns are consistent across guidance from the NHS, Mayo Clinic and the National Cancer Institute.

Most men are seen more often in the first year or two, typically every few months, then less frequently once PSA is stable. Many services move stable men to PSA testing through their primary care clinician with rapid re-referral if the number changes, a model sometimes called shared or supported follow-up.

After which treatment	What is usually checked	Typical early rhythm	Points often raised
Radical prostatectomy	PSA (expected undetectable), continence, erections, wound healing	PSA every few months in year one, then every 6–12 months if stable	Pelvic floor progress, erection rehabilitation, any leakage at climax
External beam radiotherapy or brachytherapy	PSA trend toward nadir, urinary and bowel symptoms	Similar to surgery; nadir judged over 1–2 years	PSA bounce, late bowel or bladder changes, blood in urine or stool
Radiotherapy plus time-limited hormone therapy	PSA, testosterone recovery, weight, blood pressure, sometimes bone density and blood sugar	Aligned with hormone course, then as above	Hot flashes, fatigue, mood, when testosterone is expected to return
Long-term hormone therapy	PSA, symptoms, cardiovascular and bone health	Ongoing, set by oncology	Exercise plan, fracture prevention, imaging if symptoms change

The rhythms above are typical ranges described in mainstream guidance, not fixed rules. Some men are seen more often because of higher-risk features; others less. What matters is that every man knows who to contact between visits and how to get an earlier appointment if something changes.

Bowel changes after radiotherapy and how they are managed

The rectum lies directly behind the prostate, separated by a few millimetres of tissue, so some radiation dose reaches its wall no matter how precisely the beam is shaped. Modern techniques and spacer gels, which push the rectum a little further away, have reduced exposure, but bowel effects remain a recognised part of life after prostate cancer treatment with radiotherapy.

Early effects appear during the course or in the weeks after: looser or more frequent stools, urgency, mucus, mild cramping and occasionally a feeling of incomplete emptying. The NHS describes these as common and usually easing within weeks of finishing treatment.

Late effects are less common but more persistent. Radiation proctitis, inflammation of the rectal lining, can develop months or even years later, causing bleeding, urgency or discomfort. Bleeding from fragile surface vessels is often minor but always needs assessment, because bowel cancer and other causes must be excluded rather than assumed to be radiation-related.

Practical management usually starts with diet: adjusting fibre, limiting foods that trigger loose stools, and keeping well hydrated. Anti-diarrhoeal or anti-inflammatory approaches are sometimes used under medical guidance. For persistent bleeding, gastroenterologists have several endoscopic options, and the treating team would refer if needed.

Men who had surgery rather than radiotherapy rarely experience bowel changes from the treatment itself, though constipation in the early weeks is common and worth avoiding, since straining loads the healing join and the pelvic floor.

The important message is that bowel symptoms after radiotherapy are not something to endure silently. They are documented, expected in a proportion of men, and treatable in most cases. Reporting them at follow-up, with details of frequency and any bleeding, allows the team to separate ordinary late effects from anything that needs urgent investigation.

What are the mental effects of prostate cancer and its treatment?

The psychological weight of prostate cancer often arrives late. During diagnosis and treatment, appointments provide structure and a sense of action. Afterward, the schedule empties and the mind fills the space. Men describe a paradoxical low mood in the months when everyone around them expects celebration.

Several threads contribute. Fear of recurrence is nearly universal and tends to spike before PSA tests. Changes in bladder control and sexual function strike at self-image in ways that feel hard to voice. Hormone therapy has direct effects on mood and cognition. And the sheer fatigue of treatment leaves less resilience for everything else.

The NHS living-with-prostate-cancer guidance recognises anxiety and depression as common and encourages men to seek help rather than wait for it to pass. Mayo Clinic similarly lists emotional distress among the expected consequences of a cancer diagnosis. Signs worth taking seriously include persistent low mood lasting more than a couple of weeks, loss of interest in activities that used to matter, withdrawal from family, sleep that does not improve, and thoughts that life is not worth living. Any of the latter should be raised urgently.

What helps is neither mysterious nor soft. Structured exercise has good evidence for mood in cancer survivors. Talking therapies, particularly cognitive behavioural approaches, help with fear of recurrence and adjustment. Peer support groups, in person or online, let men hear from others who have walked the same path, which many find more useful than reassurance from people who have not. When depression is more than situational, antidepressant medicines are sometimes used, always a decision for the prescribing clinician, who can check for interactions with cancer treatments.

Partners are affected too, and often carry their own anxiety without an outlet. Support services frequently welcome them, and asking is worthwhile.

Long-term pain and physical aftereffects: what is normal and what is not

Persistent pain is not a typical long-term feature of prostatectomy or radiotherapy, which is one reason men who do have it feel unheard. Understanding the common patterns helps separate expected aftereffects from problems that need attention.

After surgery, the small incisions and the deeper pelvic tissues heal over weeks. Some men notice aching or tightness in the pelvis or perineum, the area between the scrotum and anus, for a few months, particularly when sitting for long periods. Pelvic floor muscles that have been working overtime to hold urine can become tense and sore, a form of pelvic floor overactivity that a specialist physiotherapist can identify and treat with relaxation techniques rather than more squeezing.

Nerve-related sensations, including tingling or numbness near the incisions or at the tip of the penis, occur in some men and usually fade as nerves recover, though this can take many months.

If lymph nodes were removed during surgery, fluid can occasionally collect in the pelvis (a lymphocele) or cause swelling in the legs or genitals (lymphoedema). Both warrant assessment rather than assumption.

After radiotherapy, pain is less common still, but rectal discomfort from proctitis, or bladder pain from irritation, can occur. Bone pain that is new, persistent and unexplained, especially in the back, hips or ribs, is a symptom that any man with a prostate cancer history should report promptly, because the treating team will want to exclude spread to bone, even though other, more ordinary causes are far more likely.

Men on hormone therapy sometimes report joint aches and muscle stiffness, which often respond to regular movement and strength training.

The rule of thumb clinicians use: pain that improves week on week is usually healing; pain that is new, worsening or waking you at night deserves a call.

Living well after prostate cancer treatment: exercise, weight, heart and bone

Many men are surprised to learn that after localised prostate cancer treatment, heart disease is often a greater long-term threat to their health than the cancer itself. This is not a reason for alarm; it is a reason to invest in the ordinary pillars of health with fresh motivation.

Exercise is the intervention with the strongest evidence across almost every domain of recovery. Aerobic activity improves fatigue and mood. Resistance training preserves muscle and bone, which is especially important during hormone therapy. Pelvic floor work supports continence. The American Heart Association’s general guidance of at least 150 minutes of moderate activity a week, plus muscle-strengthening activity on two or more days, is a reasonable target once the surgical team clears heavier exertion, and it aligns with cancer survivorship recommendations.

Diet matters mainly through its effect on weight, blood sugar and cardiovascular risk. A pattern rich in vegetables, fruit, whole grains, legumes and fish, with limited processed meat and sugary drinks, is the approach consistently supported for both heart health and cancer survivors. No single food or supplement has been shown to prevent prostate cancer recurrence, and the NIH Office of Dietary Supplements notes that high-dose supplements can carry risks of their own; any supplement plan should be discussed with the team.

Bone health deserves specific attention for men who have had hormone therapy: weight-bearing exercise, adequate calcium and vitamin D, avoiding smoking, and moderating alcohol.

Smoking cessation improves wound healing, urinary symptoms, cardiovascular risk and the odds of further cancers. Alcohol in excess worsens sleep, mood and bladder urgency.

Finally, keep up routine screening for other conditions, including bowel cancer screening and cardiovascular checks. Surviving one cancer does not exempt anyone from the others, and general practitioners are the natural coordinators of this wider health picture.

What people often get wrong about life after prostate cancer treatment

Myths cluster around this topic because so few men talk openly about it. Correcting the most common ones removes unnecessary fear and unnecessary resignation.

“If I still leak at three months, it will never improve.” The NHS describes continence recovery continuing over many months, sometimes beyond a year, and Cleveland Clinic notes ongoing improvement well past the early phase. Three months is early in that arc.

“Erections come back or they don’t; there is nothing in between.” Nerve recovery is gradual and partial recovery is common. Cleveland Clinic describes improvement for up to two years, and rehabilitation strategies exist for men whose nerves were spared and, differently, for those whose were not.

“A rising PSA means the cancer is back and I am in trouble.” After radiotherapy, PSA bounces are recognised and benign. After surgery, a rise prompts further evaluation and, often, further treatment options, not a conclusion.

“Radiotherapy has no side effects because nothing was removed.” Radiation effects are real and can be delayed; the NHS lists urinary, bowel and sexual changes that may appear months later.

“I should feel grateful, not depressed.” Low mood after cancer treatment is common and well documented. Gratitude and grief coexist.

“A special diet or supplement will stop it coming back.” No dietary product has been shown to prevent recurrence; overall healthy eating supports general health, which is valuable in itself.

“Hormone therapy side effects are permanent.” For time-limited courses, many effects ease as testosterone recovers, though the pace varies and older men may recover more slowly.

“Dry orgasm means no orgasm.” After prostatectomy there is no ejaculate, but the sensation of orgasm remains possible for most men.

Honest information rarely makes things worse. Uncertainty does.

Questions to ask your care team at follow-up visits

Follow-up appointments are short, and men often leave with the questions they most wanted answered still unspoken. Writing them down beforehand, and bringing a partner or friend to listen, changes the quality of the conversation. The list below is a starting point; it is not exhaustive and is not a substitute for the team’s own guidance.

• What PSA level do you expect for me, given my treatment, and what change would prompt further tests?
• How many readings would you want before drawing any conclusion from a rise?
• Who should I contact between appointments if I notice a new symptom, and how quickly can I be seen?
• Is my current level of urine leakage within the range you would expect at this stage, and when would you consider further assessment or referral?
• Am I doing pelvic floor exercises correctly, and can I be referred to a pelvic health physiotherapist to check?
• What options exist for erection rehabilitation in my situation, and when is the right time to start them?
• Is it safe for me to resume sexual activity, cycling, heavy lifting or my usual sport, and from when?
• If I had hormone therapy, when do you expect testosterone to recover, and how will we know?
• Should my bone density, blood pressure, cholesterol or blood sugar be checked, and by whom?
• Which bowel or bladder symptoms after radiotherapy should I report straight away rather than mention at the next visit?
• Is there a specialist nurse, counsellor or support group you would recommend for me or my partner?
• How will my follow-up be shared between the hospital team and my primary care clinician, and what does each expect me to do?

A final question that many men find useful: “What would you want to know if you were sitting where I am?” Clinicians usually have an answer, and it is often the thing nobody thought to ask.

When to call your doctor: red-flag signs after prostate cancer treatment

Most symptoms after prostate cancer treatment are expected, gradual and manageable at scheduled visits. A smaller set should not wait. The list below reflects red flags described across NHS, Mayo Clinic and Cleveland Clinic guidance for men recovering from prostatectomy, radiotherapy or hormone therapy.

Contact your team or seek urgent care the same day if you notice:

• Inability to pass urine, or passing only small amounts with a painful, full bladder, particularly soon after catheter removal or during radiotherapy.
• Heavy or persistent blood in the urine, or clots, rather than a faint pink tinge.
• Fever, chills, or a surgical wound that becomes red, hot, swollen or leaks fluid.
• Pain, swelling or warmth in one calf, or sudden breathlessness or chest pain, which can signal a blood clot and need emergency assessment.
• Persistent or heavy bleeding from the back passage after radiotherapy, or black, tarry stools.
• Severe or worsening abdominal or pelvic pain, or repeated vomiting.
• New, persistent bone pain, especially in the back, hips or ribs, or weakness, numbness or tingling in the legs, or new difficulty controlling the bowel, which need prompt evaluation to exclude spinal involvement.
• Swelling of one leg or the genitals that does not settle.
• Thoughts of harming yourself, or a low mood that feels unmanageable.

Arrange a non-urgent but prompt appointment for urine leakage that suddenly worsens after having improved, burning or pain on urination lasting more than a few days, new bowel changes that persist beyond a few weeks, or any symptom that is steadily getting worse rather than better.

When in doubt, call. Teams would far rather hear about a symptom that turns out to be nothing than learn about a serious one late. Every decision about investigation and treatment rests with the clinicians who know your history.

Frequently asked questions

Can you live a long life after prostate cancer?

Many men do. When prostate cancer is found while still confined to the gland or nearby tissue, guidance from the National Cancer Institute and NHS describes it as very often controllable for many years, and for many men it never returns. Outcomes vary with the cancer’s grade, stage and response to treatment, so the treating team is the right source for an individual outlook. Heart health and other conditions frequently matter as much to long-term wellbeing as the cancer itself.

How should I feel with prostate cancer after treatment ends?

There is no correct way to feel. Relief, exhaustion, anxiety before PSA tests and low mood can all arrive together, often in the months after treatment when appointments stop. Physical symptoms such as leakage, fatigue and sexual changes are common and usually improve gradually. If sadness, worry or withdrawal persists for more than a couple of weeks, or interferes with daily life, raise it with your team; emotional support is part of cancer care, not an afterthought.

What is a typical prostate cancer recovery timeline after surgery?

Broadly, the catheter is usually removed one to two weeks after prostatectomy, wounds heal over a few weeks, and heavy activity is often restricted for several weeks. Bladder control improves over months, with the NHS noting some men continue to leak for up to a year or more. Erections recover most slowly, with Cleveland Clinic describing improvement for up to two years. Exact timings vary and are guided by the surgical team.

How long does incontinence after prostatectomy usually last?

Most men leak when the catheter comes out and improve steadily over the following weeks and months. The NHS states that most regain control within a few months, while a proportion take up to a year or longer. Pelvic floor exercises, started when the team advises, are the main supported strategy. If significant leakage persists beyond about a year, urologists typically discuss further assessment and treatment options at that stage.

What are normal PSA levels after prostate surgery?

After radical prostatectomy the whole gland is removed, so PSA is expected to fall to an undetectable or near-zero level within a few weeks and stay there. A subsequent sustained rise, confirmed over more than one test, is what clinicians call biochemical recurrence and prompts further evaluation. After radiotherapy the expectation is different: PSA falls slowly to a low point rather than zero, and temporary bounces are recognised. Ask your team what range applies to you.

What does sex after prostate cancer treatment usually look like?

Usually different, not absent. After surgery, orgasm remains possible but without ejaculate, erections are often weaker initially and can improve over one to two years, and some men notice reduced length or minor urine leakage at climax. After radiotherapy, erection changes tend to develop more gradually. Hormone therapy lowers desire itself. Rehabilitation options exist and should be discussed with the urology team, ideally with a partner present, as early as the man feels ready.

What are the mental effects of prostate cancer?

Anxiety, particularly around PSA tests, and low mood are common and recognised by the NHS and Mayo Clinic as part of the cancer experience. Changes to continence and sexual function affect self-image, and hormone therapy has direct effects on mood, energy and concentration. Persistent low mood, loss of interest, poor sleep or thoughts of self-harm should be raised promptly. Exercise, talking therapies and peer support all have evidence of benefit, and partners often need support too.

What are the long-term pain side effects of prostatectomy?

Persistent pain is not a typical long-term outcome. Some men have pelvic or perineal aching for a few months, often from tense, overworked pelvic floor muscles, and tingling or numbness near incisions that fades as nerves recover. Lymph node removal can occasionally cause fluid collections or leg swelling. New, worsening or night-time pain, especially in bones, is not expected and should be reported so the team can investigate rather than assume a cause.

Do side effects of hormone therapy go away?

For a time-limited course, many effects such as hot flashes, fatigue and low libido ease as testosterone recovers, though this can take many months and tends to be slower in older men and after longer treatment. Some changes, including reduced bone density and altered body composition, may need active management with exercise and monitoring. For men on long-term therapy, side effects are managed on an ongoing basis by the oncology team.

How often are follow-up visits after prostate cancer treatment?

Typically more often in the first year or two, commonly every few months for PSA and symptom review, then every six to twelve months once stable, according to patterns described by the NHS and Mayo Clinic. Many services move stable men to PSA monitoring through primary care with quick re-referral if the number changes. The exact schedule depends on cancer risk and treatment type and is set by the treating team.

References

• NHS: Prostate cancer, treatment
• NHS: Prostate cancer, living with
• MedlinePlus: Prostate cancer

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.